ALDH1A1 and breast cancer: However, the direct relationship among ALDH1A1, PD-L1 and TILs observed in the cohort should be explored in a larger population before its translation to any clinical setting, as they may be potential targets for combined therapeutic modalities including standard chemotherapy, targeted agents and immunotherapy in specific BC subtypes.